FDA Approves First Canine Cancer Drug

FDA Approves First Canine Cancer Drug

FDA approves first drug for canine cancer

The Food and Drug Administration approved today the nation’s first drug developed specifically for the treatment of canine cancer.

Manufactured by Pfizer Animal Health Inc., based in New York City, the drug marketed as Palladia, or chemically known as toceranib phosphate, will hit the markets in early 2010.

Continue reading… “FDA Approves First Canine Cancer Drug”

0